Given the choice of contrast medium for a computed tomography (CT) scan, most patients wouldn’t know the difference between the two iodine-based options commonly used in cancer cases. But for some patients, particularly in the already fragile and...
7-Aug-2017 11:05 AM EDT Add to Favorites
Researchers analyzed data confirming the improved outcomes in both short- and long-term survival in patients that underwent neoadjuvant chemotherapy prior to surgery for triple-negative breast cancer. The study included 213 patients at 8 Italian...
25-Jul-2017 11:05 AM EDT Add to Favorites
A new study of non-diabetic women with ovarian cancer reveals a potential correlation and area for further study regarding the expression of the GLUT1 glucose transporter receptor at the cancer tissue level. GLUT1 is a receptor protein involved in...
30-May-2017 7:05 AM EDT Add to Favorites
A new study suggests that the use of tomato — a key food of the Mediterranean diet — should be explored to develop supportive strategies against gastric cancer
13-May-2017 12:05 AM EDT Add to Favorites
Giordano is joined on the board by Corporation for Public Broadcasting President and CEO Patricia de Stacy Harrison and former Talk America President, Chairman and CEO Gabriel A. Battista who will serve as co-chairperson of the Foundation
29-Mar-2017 2:05 PM EDT Add to Favorites
The most recent global cancer data from the WHO highlights the growing differences in mortality rate among regions of the world bearing very different economic circumstances.
7-Mar-2017 1:00 PM EST Add to Favorites
The organization is praising a group of Italian filmmakers for their contribution to medicine through the arts. Their film, Ho Amici In Paradiso [I Have Friends in Heaven], will screen this week at the Los Angeles Italia Film, Fashion, and Art Fest....
21-Feb-2017 1:05 PM EST Add to Favorites
Only 25% of patients respond to sorafenib treatment, so researchers have endeavored to understand its mechanism of action and discover a way to boost its effectiveness.
17-Feb-2017 3:05 PM EST Add to Favorites
Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT
“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST